-
公开(公告)号：WO2013181576A2
公开(公告)日：2013-12-05
申请号：PCT/US2013/043675
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John , COLLINS, Brian, Edward , KAUNDINYA, Ganesh , BOSQUES, Carlos, J.
IPC: G01N33/53
CPC classification number: G01N33/6854 , C07K16/00 , C07K2317/41 , G01N2440/38
Abstract: Methods of making and evaluating biologic therapeutic products are disclosed.
Abstract translation: 公开了制备和评价生物治疗产品的方法。
-
公开(公告)号：WO2013181572A3
公开(公告)日：2013-12-05
申请号：PCT/US2013/043671
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John , COLLINS, Brian, Edward , KAUNDINYA, Ganesh , BOSQUES, Carlos, J.
Abstract: The present invention relates to the characterization and production of panitumumab.
-
公开(公告)号：WO2013181585A2
公开(公告)日：2013-12-05
申请号：PCT/US2013/043693
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC. , COLLINS, Brian, Edward
Inventor： COLLINS, Brian, Edward , ROBBLEE, John , KAUNDINYA, Ganesh , BOSQUES, Carlos, J.
IPC: G01N33/53
CPC classification number: C07K16/241 , C07K2317/21 , G01N33/577 , G01N33/6854 , G01N2333/4728 , G01N2333/525 , G01N2440/38
Abstract: The present invention relates to the characterization and production of adalimumab.
Abstract translation: 本发明涉及阿达木单抗的表征和制备。
-
公开(公告)号：WO2013181577A2
公开(公告)日：2013-12-05
申请号：PCT/US2013/043676
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John , COLLINS, Brian, Edward , KAUNDINYA, Ganesh , BOSQUES, Carlos, J.
IPC: G01N33/53
CPC classification number: C07K16/4291 , C07K16/42 , C07K2317/24 , C07K2317/41 , G01N33/6854
Abstract: The present invention relates to the characterization and production of omalizumab.
Abstract translation: 本发明涉及奥马珠单抗的表征和生产。
-
公开(公告)号：WO2017117218A1
公开(公告)日：2017-07-06
申请号：PCT/US2016/068871
申请日：2016-12-28
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John
IPC: A61K39/395 , C12P21/00 , G01N33/68
CPC classification number: C12P21/005 , C07K16/244 , C07K2317/14 , C07K2317/21 , C07K2317/30 , C07K2317/41 , G01N33/68
Abstract: The present disclosure relates to the characterization and production of biologics.
Abstract translation: 本公开涉及生物制品的表征和生产。
-
Patent Agency Ranking
公开(公告)号：WO2013181571A2
公开(公告)日：2013-12-05
申请号：PCT/US2013/043670
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John , COLLINS, Brian, Edward , KAUNDINYA, Ganesh , BOSQUES, Carlos, J.
CPC classification number: C07K16/3015 , C07K14/71 , C07K16/32 , C07K2317/24 , G01N33/6854
Abstract: The present invention relates to the characterization and production of trastuzumab.
Abstract translation: 本发明涉及曲妥珠单抗的表征和生产。
-
公开(公告)号：WO2013181568A2
公开(公告)日：2013-12-05
申请号：PCT/US2013/043667
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John , COLLINS, Brian, Edward , KAUNDINYA, Ganesh , BOSQUES, Carlos, J.
IPC: G01N33/53
CPC classification number: C07K16/2893 , C07K2317/24 , C07K2317/41
Abstract: The present invention relates to the characterization and production of alemtuzumab.
Abstract translation: 本发明涉及alemtuzumab的表征和生产。
-
公开(公告)号：WO2016176275A1
公开(公告)日：2016-11-03
申请号：PCT/US2016/029472
申请日：2016-04-27
Applicant: MOMENTA PHARMACEUTICALS, INC. , BIOFACTURA, INC.
Inventor： TIJANI, Rasheed , SAMPEY, Darryl, Bacon , ROBBLEE, John , WEI, Gan
CPC classification number: C12P21/00 , C07K16/00 , C07K2317/14 , C12P21/02 , C12Y101/0127 , C12Y603/01002
Abstract: Disclosed herein are methods of manufacturing therapeutic proteins.
Abstract translation: 本文公开了制备治疗性蛋白质的方法。
-
公开(公告)号：WO2014149067A1
公开(公告)日：2014-09-25
申请号：PCT/US2013/043786
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John , HE, Xiaomei , YIN, Yan , LIN, Yin, Yin , COLLINS, Brian , MURPHY, Jennifer , KAUNDINYA, Ganesh, V.
IPC: C07K19/00
CPC classification number: C07K14/70521 , C07K2319/30
Abstract: The present disclosure provides, in part, methods for evaluating, identifying, and/or producing (e.g., manufacturing) a CTLA4-Fc fusion protein, e.g., abatacept. In some instances, methods herein allow highly resolved evaluation of abatacept useful for, inter alia, manufacturing abatacept, characterizing abatacept, identifying and/or confirming abatacept, monitoring the structure of abatacept, comparing abatacept preparations made over time or made under different conditions, and/or controlling the structure of abatacept.
Abstract translation: 本公开部分地提供用于评估，鉴定和/或产生（例如制造）CTLA4-Fc融合蛋白（例如abatacept）的方法。 在某些情况下，这里的方法允许高度分辨的对abatacept的评估，特别是制造abatacept，表征abatacept，鉴定和/或确认abatacept，监测abatacept的结构，比较随时间推移或在不同条件下制备的abatacept制剂， /或控制abatacept的结构。
-
公开(公告)号：WO2013181599A2
公开(公告)日：2013-12-05
申请号：PCT/US2013/043710
申请日：2013-05-31
Applicant: MOMENTA PHARMACEUTICALS, INC.
Inventor： ROBBLEE, John , COLLINS, Brian, Edward , KAUNDINYA, Ganesh , BOSQUES, Carlos, J.
IPC: G01N33/53
CPC classification number: C07K16/2887 , C07K2317/10 , C07K2317/24 , C07K2317/41
Abstract: The present invention relates to the characterization and production of rituximab.
Abstract translation: 本发明涉及利妥昔单抗的表征和生产。
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.021 seconds)
